29-Jun-2026 22:36:35
BIOCONAcquisition and merger
BIOCON LIMITED : ACQUISITION OF EQUITY SHARES OF BBL AND ALLOTMENT OF EQUITY SHARES OF BIOCON LIMITED
• Completed acquisition of 1,15,36,956 equity shares of Biocon Biologics Limited (BBL) from 127 selling shareholders • Allotted 87,86,362 equity shares of Biocon Limited at an issue price of ₹376.41 per share • Post-allotment, BBL becomes a wholly-owned subsidiary of Biocon Limited • Issued and paid-up equity share capital increased from ₹810.45 Cr to ₹814.85 Cr
Biocon Ltd
Open attachment